Analyst Ratings for PRA Health Sciences Inc. (PRAH)

Updated: 2017-07-26

An average rating of Buy has been given to PRA Health Sciences Inc. (NASDAQ:PRAH) by analysts covering the stock. Last month, PRAH received an average rating of Buy.

8 analysts declared PRAH a buy, 1 gave an overweight rating, 1 gave a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

Several price targets were given for PRAH by the analysts covering the stock. The highest price target was 90, which equates to a potential upside of 17.17 percent. The lowest price target was 69, implying a possible loss of -10.17 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. That number becomes -0.68 percent if we expand the time horizon to include the past 3 months instead of just one. Meanwhile, fiscal year estimates have been revised upwards by 0.16 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 0.32 percent.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, which can be compared to the 0 analysts that decreased their estimates. Also over the last month, 0 analysts increased their estimates for the FY earnings, compared to 0 analysts that revised their FY estimates downwards.

PRAH has an estimated earnings growth rate of 79.29 percent as forecasted by analysts. People on Wall Street often look at a company's PEG ratio. A lower PEG ratio is favorable, because people typically see that as an indicator of higher growth relative to stock price. Many investors consider PEG ratios between 0 and 1 as preferrable, although it is frequently more appropriate to compare PEG ratios to the company's peers. PRAH has a PEG ratio of 0.57.

PRAH has traded between a high of 79.98 and a low of 43.08 over the past year. Currently the stock is 78.3 percent higher than its low, and 3.96 percent lower than its 52-week high. PRAH has a P/E ratio of 45.18. Investors typically compare the P/E ratio to a company's peers in the industry. The PRAH value stock report compares PRAH to some of its peers using value stock charts. The market cap of PRAH is $4.8 billion. PRAH is estimated to release their earnings results for the quarter on 0000-00-00, days from today.